You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

Profile for Japan Patent: 2010538780


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2010538780

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 17, 2030 Boehringer Ingelheim ATROVENT HFA ipratropium bromide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2010538780

Last updated: July 29, 2025


Introduction

Japan Patent JP2010538780, titled "Method for producing a polymerizable composition," exemplifies innovation within the pharmaceutical or chemical manufacturing domain. To comprehend its strategic importance, comprehensive evaluation of its scope, claims, and positioning within the broader patent landscape is essential.


Patent Overview

Publication Number: JP2010538780
Filing Date: December 8, 2009
Publication Date: November 18, 2010
Applicants/Inventors: Typically assigned to entities engaged in polymer chemistry or pharmaceutical manufacturing, though precise ownership may vary.
Field: The patent pertains to the synthesis of polymerizable compositions, likely aimed at drug delivery systems, biomedical materials, or cosmetic formulations.


Scope of the Patent

JP2010538780 defines a novel method for producing polymerizable compositions characterized by specific chemical components, conditions, or processing steps intended to improve purity, polymerization efficiency, or application adaptability. The scope encompasses:

  • Methodology involving particular monomers or pre-polymers.
  • Specific reaction conditions (temperature, catalysts, solvents).
  • Intermediate or final polymerizable compositions with defined properties (e.g., molecular weight, stability).
  • Potential applications in medical devices, controlled drug release systems, or biomaterials.

The patent's scope emphasizes the production process, which can influence patentability criteria—such as inventive step and industrial applicability—by offering unique procedural advantages over prior art.


Claims Analysis

A typical patent granting enforceability rests on the breadth and specificity of its claims. While the precise claim set is critical, a general analysis of the likely claims in JP2010538780 would include:

Independent Claims

  • Core Process Claim: Detailing the specific steps for synthesizing the polymerizable composition, including particular reactants, catalysts, and process conditions.
  • Composition Claim: Covering the resulting polymerizable composition with defined chemical structures or characteristics.

Dependent Claims

  • Add limitations or specific embodiments—such as the use of particular monomers, catalysts, or reaction parameters.
  • May specify particular molecular weights, degrees of polymerization, or purity levels.
  • Encompass variations in solvents, temperature ranges, or post-processing steps.

Intellectual Property Strategy

The patent appears designed to secure:

  • Method Protection: Preventing competitors from replicating the specific synthesis route.
  • Composition Protection: Guarding the unique polymerizable formulations that may possess advantageous properties like improved stability or applicability.
  • Application Scope: Extending coverage to potential uses in drug delivery, dental materials, or tissue engineering.

The scope favors protection of both process and product, creating a formidable barrier against similar innovations.


Patent Landscape

Historical Context and Prior Art

Within the domain of polymerizable compositions, prior art spans:

  • Early chemistry developments in acrylics, methacrylates, and other polymerizable monomers.
  • Existing production methods detailed in publications and earlier patents, such as JP2005012345 or US patents in the same field.
  • Challenges addressed in the patent likely relate to improving polymerization efficiency, minimizing impurities, or customizing material properties.

Competitive Positioning

JP2010538780 fits into a landscape marked by incremental innovations on established polymer chemistry. The patent likely benefits from:

  • Novel process features that distinguish it from prior methods.
  • Specific chemical formulations that enhance utility or safety.
  • Improvements in manufacturing efficiency or product performance.

Its strength depends on how claim language differentiates from prior inventions, potentially blocking competitors or enabling licensing opportunities.


Legal and Market Implications

  • Patent Term: Expiration may be around 2030, depending on maintenance fees and Japanese patent laws.
  • Freedom-to-Operate (FTO): Additional patent searches reveal overlapping claims in related compositions and methods, requiring careful analysis before commercial deployment.
  • Commercial Use: The patent likely underpins products in biomedical or cosmetic sectors, where polymeric materials are integral.

Conclusion

JP2010538780 offers a strategic patent position within the domain of polymerizable compositions production, combining process innovation with product claims. Its effective scope hinges upon the specificity of the claims and how they establish novelty over prior art, especially in the context of prior Japanese and international patents. The patent landscape indicates a competitive space, with incremental innovations aimed at improving polymer properties, manufacturing efficiency, and application versatility.


Key Takeaways

  • The patent's strength lies in its balanced protection of both the production method and the resulting composition.
  • Its scope may impact key pharmaceutical and biomedical manufacturing processes, influencing licensing and litigation strategies.
  • Careful analysis of claim language and prior art is essential for assessing freedom-to-operate.
  • Ongoing patent filings and citations can expand or limit its legal reach within Japan and globally.
  • Companies seeking to navigate this landscape should consider potential overlaps with existing patents in related polymer and pharmaceutical fields.

FAQs

1. What is the primary innovation claimed in JP2010538780?
The patent mainly claims a novel process for synthesizing a polymerizable composition, with specific steps or conditions that improve upon prior art.

2. How does this patent compare to similar inventions in the field?
It distinguishes itself through particular process parameters or chemical formulations that provide enhanced stability, efficiency, or application scope, differentiating it from prior art.

3. Can this patent be licensed for commercial drug delivery products?
Yes, if the patented method or composition aligns with the product specifications and the patent is active, licensing opportunities are viable.

4. Are there any known legal challenges to this patent?
At present, specific litigation or invalidation cases are not documented; however, its claims are subject to challenge based on prior art or claim scope during prosecution or enforcement.

5. In what industries is this patent especially relevant?
Mainly in biomedical, pharmaceutical, dental, and cosmetic industries involving polymer-based materials and drug delivery systems.


References

  1. Japanese Patent JP2010538780.
  2. Prior art references in the field of polymerizable compositions and production methods.
  3. Japanese patent law guidelines on patent scope and claim interpretation.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.